Binding Agreement to Acquire Substantially All NanoString Assets for $220 Million Pending Bankruptcy Court Approval Agreement Represents Major Step in Financial Restructuring and Provides Continuity for Customers and Employees SEATTLE -- NanoString Technologies, Inc. (OTC: NSTGQ) (“NanoString” or the “Company”), a leading provider of life science tools for discovery and translational research, today announced that it has [...]

CAMECA is delighted to announce the launch of the NanoSIMS-HR, successor of the world-acclaimed NanoSIMS 50/50L Secondary Ion Mass Spectrometer series which have contributed to major advances in the most diverse fields of fundamental research and industrial innovation: material sciences and semiconductor, geo- and cosmochemistry, plant and soil sciences, environmental microbiology, cell biology and medical research. [...]

Cambridge, Mass. - Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has announced a significant capital raise to fuel its continued growth and execution of long-term vision. At the same time, the company has also taken steps to streamline its operations and reduce headcount. These measures [...]

BOHEMIA, NY -- Scientific Industries, Inc. ("SI") (OTCQB:SCND) announced the appointment of John Nicols to the Board of Directors of SI and Chairman of its wholly, owned subsidiary, Scientific Bioprocessing Inc. ("SBI"), effective March 4, 2024. Mr. Nicols replaces Mr. John A. Moore as Chairman of SBI. John A. Moore, Chairman of SI, said "We are [...]

BASEL, Switzerland --  Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider of automated laboratory R&D and QC workflow solutions. This acquisition, first announced in January 2024, marks another significant milestone in Bruker’s expansion in vendor-agnostic scientific software, R&D and QC digitalization, and [...]

The PromethION 2 Integrated sets a new standard for convenience and efficiency in DNA, RNA, and cDNA sequencing. With its onboard computing capabilities, the self-contained device is bringing high-quality sequencing to a wider range of research and academic labs.  Oxford Nanopore Technologies today announced the early access launch of its all-in-one desk top sequencing device, [...]

PROVIDENCE, R.I. -- Next generation genomic tools company, Nabsys®, has executed a nonexclusive agreement with Canadian distributor, DMark Biosciences ("DMark"), for sales of its OhmX™ platform. OhmX is Nabsys' first commercially available product and was released in October 2023. DMark will be responsible for distributing both the Nabsys OhmX™ Analyzer and consumables into both public and private research core [...]

FREMONT, Calif. -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that it has opened a new 50,000-square-foot facility in Wuxi, China. This strategic move increases the company's manufacturing capacity to meet the growing worldwide demand for comprehensive cell analysis solutions. The Wuxi facility offers the advantage of fostering unique vendor [...]

BOXBOROUGH MA. --RedShiftBioAnalytics, Inc. (RedShiftBio), a provider of innovative analytical solutions for the measurement of protein characterization and protein concentration used in biotherapeutic drug development and manufacturing, proudly announces the appointment of Tom O’Lenic as its new Chief Executive Officer (CEO). With over two decades of experience in commercial leadership and management roles, O’Lenic brings [...]

WALTHAM, Mass. -- NanoMosaic, the multiplex and multi-omic quantification company, today announced the expanded capabilities and availability of assays optimized on its Tessie™ system for use in gene therapy applications. The platform combines the ability to quantify proteins and nucleic acids in a single run, enabling the simultaneous detection and characterization of adeno-associated virus (AAV) [...]